129 related articles for article (PubMed ID: 12142636)
1. Free and glucuronidated olanzapine serum concentrations in psychiatric patients: influence of carbamazepine comedication.
Linnet K; Olesen OV
Ther Drug Monit; 2002 Aug; 24(4):512-7. PubMed ID: 12142636
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine serum concentrations in psychiatric patients given standard doses: the influence of comedication.
Olesen OV; Linnet K
Ther Drug Monit; 1999 Feb; 21(1):87-90. PubMed ID: 10051059
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting.
Skogh E; Reis M; Dahl ML; Lundmark J; Bengtsson F
Ther Drug Monit; 2002 Aug; 24(4):518-26. PubMed ID: 12142637
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine serum concentrations in psychiatric patients: the influence of comedication.
Hasselstrøm J; Linnet K
Ther Drug Monit; 2004 Oct; 26(5):486-91. PubMed ID: 15385830
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring of serum olanzapine during antipsychotic treatment].
Linnet K; Olesen OV
Ugeskr Laeger; 2000 Sep; 162(36):4802-5. PubMed ID: 10994377
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine serum concentrations lowered by concomitant treatment with carbamazepine.
Licht RW; Olesen OV; Friis P; Laustsen T
J Clin Psychopharmacol; 2000 Feb; 20(1):110-2. PubMed ID: 10653223
[No Abstract] [Full Text] [Related]
7. Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine.
Carrillo JA; Herráiz AG; Ramos SI; Gervasini G; Vizcaíno S; Benítez J
J Clin Psychopharmacol; 2003 Apr; 23(2):119-27. PubMed ID: 12640212
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism.
Lucas RA; Gilfillan DJ; Bergstrom RF
Eur J Clin Pharmacol; 1998 Oct; 54(8):639-43. PubMed ID: 9860152
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of olanzapine and its N-desmethyl and 2-hydroxymethyl metabolites in child and adolescent psychiatric disorders: effects of dose, diagnosis, age, sex, smoking, and comedication.
Theisen FM; Haberhausen M; Schulz E; Fleischhaker C; Clement HW; Heinzel-Gutenbrunner M; Remschmidt H
Ther Drug Monit; 2006 Dec; 28(6):750-9. PubMed ID: 17164690
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication.
Gex-Fabry M; Balant-Gorgia AE; Balant LP
Ther Drug Monit; 2003 Feb; 25(1):46-53. PubMed ID: 12548144
[TBL] [Abstract][Full Text] [Related]
11. The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers.
Markowitz JS; Devane CL; Liston HL; Boulton DW; Risch SC
Clin Pharmacol Ther; 2002 Jan; 71(1):30-8. PubMed ID: 11823755
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine drug interactions in a TDM material.
Böttiger Y; Svensson JO; Ståhle L
Ther Drug Monit; 1999 Apr; 21(2):171-4. PubMed ID: 10217336
[TBL] [Abstract][Full Text] [Related]
13. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants.
Gardiner SJ; Kristensen JH; Begg EJ; Hackett LP; Wilson DA; Ilett KF; Kohan R; Rampono J
Am J Psychiatry; 2003 Aug; 160(8):1428-31. PubMed ID: 12900304
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.
Melkersson KI; Hulting AL; Brismar KE
J Clin Psychiatry; 2000 Oct; 61(10):742-9. PubMed ID: 11078035
[TBL] [Abstract][Full Text] [Related]
15. Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.
Spina E; D'Arrigo C; Santoro V; Muscatello MR; Pandolfo G; Zoccali R; Diaz FJ; de Leon J
Ther Drug Monit; 2009 Dec; 31(6):758-63. PubMed ID: 19865002
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment.
Schoretsanitis G; Haen E; Gründer G; Stegmann B; Schruers KR; Hiemke C; Lammertz SE; Paulzen M
J Clin Psychopharmacol; 2016 Dec; 36(6):554-561. PubMed ID: 27811552
[TBL] [Abstract][Full Text] [Related]
17. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
Svinarov DA; Pippenger CE
Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
[TBL] [Abstract][Full Text] [Related]
18. Applicability of an assay for routine monitoring of highly variable concentrations of olanzapine based on HPLC with mass spectrometric detection.
Gervasini G; Vizcaíno S; Herráiz AG; Benítez J; Carrillo JA
Clin Chem; 2003 Dec; 49(12):2088-91. PubMed ID: 14633885
[No Abstract] [Full Text] [Related]
19. Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate.
Spina E; Avenoso A; Facciolà G; Salemi M; Scordo MG; Giacobello T; Madia AG; Perucca E
Ther Drug Monit; 2000 Aug; 22(4):481-5. PubMed ID: 10942191
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine excretion in human breast milk: estimation of infant exposure.
Croke S; Buist A; Hackett LP; Ilett KF; Norman TR; Burrows GD
Int J Neuropsychopharmacol; 2002 Sep; 5(3):243-7. PubMed ID: 12366877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
